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Background: Previous studies have suggested that physical exercise can reduce symptoms
for subjects suffering from panic disorder (PD). The efﬁcacy of this intervention has so far not
been compared to an established psychotherapy, such as cognitive behaviour therapy (CBT).
Assessment of controlled long-term effects and the clinical signiﬁcance of the treatment are
also lacking. Aim: To compare physical exercise to CBT as treatment for PD, and assess
controlled long-term and clinically signiﬁcant effects. Method: PD-patients were randomized
to either three weekly sessions of physical exercise (n = 17), or one weekly session of CBT
(n = 19). Both treatments ran for 12 weeks, were manualized and administered in groups.
Patients were assessed twice before the start of treatment, at post-treatment and at 6 and
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12 months thereafter. Primary outcome-measures consisted of the Mobility Inventory (MI),
the Agoraphobia Cognitions Questionnaire (ACQ) and the Body Sensations Questionnaire
(BSQ). Results: A two-way repeated measures MANOVA of these measures demonstrated a
signiﬁcant effect of time, F(16, 544) = 7.28, p< .01, as well as a signiﬁcant interaction effect,
F(16, 544) = 1.71, p < .05, in favour of CBT. This ﬁnding was supported by the assessment
of clinically signiﬁcant changes of avoidant behaviour and of treatment-seeking one year later.
Conclusion: Group CBT is more effective than group physical exercise as treatment of panic
disorder, both immediately following treatment and at follow-up assessments.
Keywords: Exercise, cognitive behaviour therapy, panic disorder, anxiety.
Introduction
Physical exercise has long been investigated as a treatment option for anxiety disorders. A
large number of studies have demonstrated the ability of exercise to reduce anxiety levels, with
the majority of these studies conducted using healthy volunteers (Long and van Stavel, 1995;
Wipﬂi, Rethorst and Landers, 2008). Meta-analyses have also indicated that physical exercise
can be effective for subjects with elevated levels of anxiety (Petruzzello, Landers, Hatﬁeld,
Kubitz and Salazar, 1991), and that it can reduce anxiety in patients suffering from somatic
disorders (Herring, O’Connor and Dishman, 2010). However, few studies have evaluated
the clinical efﬁcacy of physical exercise among patients primarily suffering from an anxiety
disorder. In one case report from 1974, Orwin used bouts of physical exercise to facilitate
the treatment of situational phobia (Orwin, 1974). Sexton, Maere and Dahl (1989) found
that physical exercise reduced anxiety levels in a mixed sample of anxious and depressed
inpatients.
To the best of our knowledge, three studies have investigated the use of physical exercise
as a treatment for patients with panic disorder (PD). Martinsen, Sandvik and Kolbjørnsrud
(1989) conducted a naturalistic study with a mixed inpatient sample in which groups of
eight patients participated. Exercise sessions were supervised with treatment involving at
least one hour of exercise daily. A signiﬁcant reduction of symptoms was observed among
PD-patients following the exercise treatment. However, the treatment effect was not found
to be signiﬁcant at the 12-month follow-up assessment. Broocks et al. (1998) conducted a
randomized controlled trial (RCT) comparing the effects on PD of physical exercise, placebo,
or the tricyclic antidepressant clomipramine. Participants in that study were required to
complete a four-mile route three times per week, either by walking or preferably by running.
In addition, they participated in a supervised group exercise session once a week. The authors
concluded that clomipramine produced a greater and more rapid treatment effect than physical
exercise. However, physical exercise was comparable to clomipramine on certain outcome
measures and was more efﬁcacious than placebo. These ﬁndings were partly supported in
Wedekind et al. (2010), where paroxetine and pill placebo were compared in combination with
either exercise or relaxation. The physical exercise was conducted according to procedures in
Broocks et al. (1998). The authors concluded that physical exercise was better than placebo,
but less effective than paroxetine. Unfortunately, no follow-up assessment was conducted for
either of these studies, leaving the controlled long-term effects of physical exercise largely
unknown.
Physical exercise has also been found to effectively reduce anxiety sensitivity (Broman-
Fulks, Berman, Rabian and Webster, 2004; Broman-Fulks and Storey, 2008; Smits et al.,
Physical exercise for panic disorder 3
2008) in subjects with elevated levels of sensitivity to anxiety and anxiety symptoms. In
these studies, physical exercise was performed for a total of six sessions over a 2-week
period. Though these studies were conducted using subjects that were not diagnosed with PD,
sensitivity to anxiety has been shown to be an important aspect of PD (Schmidt, Lerew and
Jackson, 1999). Furthermore, it has been shown that physical exercise can have an acute anti-
panic effect both in healthy volunteers (Esquivel, Schruers, Kuipers and Griez, 2002; Smits,
Meuret, Zvolensky, Rosenﬁeld and Seidel, 2009; Strohle et al., 2005) and in patients suffering
from PD (Esquivel et al., 2008; Strohle et al., 2009). Which physiological and psychological
mechanisms underlie the anxiolytic and anti-panic effects of physical exercise are still not
clear. One possible mechanism is exposure to bodily sensations, which is known to be highly
relevant to PD-patients (Chambless, Caputo, Bright and Gallagher, 1984).
In summary, an increasing amount of research suggests that physical exercise can be an
important intervention for PD. However, to the best of our knowledge, no study has previously
compared physical exercise to an established psychotherapy. Recent research has called for
physical exercise to be compared to relevant treatment options, such as cognitive behaviour
therapy (CBT; Broman-Fulks et al., 2004). Furthermore, it has been suggested that the clinical
relevance of physical exercise, as well as its long-term effects on symptom improvement,
should be assessed within a clinical context (Lawlor and Hopker, 2001; Salmon, 2001). CBT
is currently regarded as the treatment of choice for PD (McHugh et al., 2007; National Institute
for Health and Clinical Excellence, 2004), making it a suitable intervention against which
physical exercise can be compared. It has shown that CBT for PD can be effectively delivered
in group format (Telch et al., 1993).
The current study seeks to investigate the effects of physical exercise on PD in accordance
with the recommendations mentioned above. By comparing group physical exercise to group
CBT with a long-term follow-up, both the durability and the clinical effect of physical exercise
can be assessed and compared with an established treatment option for PD. It was expected
that physical exercise would yield large effects in its own right, though we predicted that
between-groups comparisons would be in favour of CBT, based on results from previous
studies (Clark et al., 1994; Broocks et al., 1998). Furthermore we wanted to assess the
magnitude of long-term, clinically signiﬁcant changes of group physical exercise compared
to group CBT.
Method
Participants
Thirty-six individuals between the ages of 18 and 50 years met the diagnostic criteria for
PD with or without agoraphobia according to the Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV-TR; American Psychiatric Association, 2000). The presence
of PD was established through the administration of the Structured Clinical Interview for
DSM-IV axis I Disorders (SCID-I; First, Spitzer, Gibbon and Williams, 1995) by a trained
clinical psychologist (the ﬁrst author). Participants were excluded if they fulﬁlled any of the
following criteria at the time of the study: (1) brain-organic disorders; (2) psychotic disorders;
(3) substance-abuse, including habitual use of benzodiazepines; (4) medical conditions that
precluded participation in physical exercise; or (5) severe major depressive episode.
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Exclusion according to criteria (1), (3) and (5) was established through the administration
of the SCID-I, whereas criteria (2) and (4) were assessed by interview with the participant,
and if necessary, by a consultation with the participant’s general practitioner (GP). All
participants were also interviewed with the Structured Clinical Interview for DSM-IV Axis
II Personality Disorders (SCID-II; First, Spitzer, Gibbon, Williams and Benjamin, 1994)
prior to treatment. For health and safety reasons, all participants were screened for risk-
factors related to heart disease (e.g. a family history of cardiac disease, hypercholesterolemia,
diabetes, hypertension or smoking) in co-operation with a cardiologist. Upon detection of risk-
factors, the participant’s GP was contacted with a request for a cardiac evaluation. Participants
using psychotropic medication were requested to stabilize this use both during the treatment
period and for 2 weeks before and after this period. Their use of psychotropic medication was
monitored throughout participation.
Recruitment
The study was conducted in a day-care unit at a district psychiatric centre (DPS) in the
municipality of Bergen, Norway. All GPs, psychologists, psychiatrists and primary health
care services in the region (a geographic area with a population of 45,000) were invited to
refer patients suffering from PD for treatment. The majority of participants were, however,
recruited through advertisements in the local press (83%).
All participants were required to provide written informed consent prior to enrolment. The
present study was approved by the Regional Committee for Medical and Health Research
Ethics in Western Norway and by the Norwegian Social Science Data Services. The study is
registered at ClinicalTrials.gov (identiﬁer: NCT01076777).
Procedure
Initial contact was established by telephone, where subjects were provided with information
about the nature of the study. At this stage, potential participants were screened for
eligibility according to the inclusion and exclusion criteria by a clinical psychologist
(the ﬁrst author). Subjects who potentially fulﬁlled the criteria for participation were
scheduled for an on-site evaluation, during which informed consent was obtained. Subjects
were prior to treatment initiation informed that both interventions had been shown to
be effective for panic disorder, but that these effects were better documented for CBT.
Following the signing of the informed consent a structured clinical interview (SCID-I) was
conducted. Once eligibility was established, participants completed the baseline assessment.
As both interventions were conducted in groups of eight or less participants, a sufﬁcient
number (twice the maximal group, e.g. 16) of participants had to be recruited before
randomization could take place. Therefore, depending on when they entered the study,
participants had to wait a variable period (a mean of 68 days) following the baseline
assessment before the pre-treatment assessment was conducted. Participants were then
immediately randomized and allocated to one of the two interventions. Further assessments
were conducted immediately post-treatment and at 6- and 12-month follow-ups. With the
exception of the 12-month follow-up, all assessments were conducted on-site at the DPS.
For the 12-month follow-up assessment, the outcome measures were sent by postal mail
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to the participants. A total of three rounds of recruitments, allocations and treatments were
completed.
Allocation. Participants were randomly assigned to either of the two treatment conditions.
Randomization was performed electronically (http://www.randomizer.org) at a location
removed from the treatment centre. The person (the last author) conducting the randomization,
received only reference-codes, and was hence completely blind to the participants’ identities
and personal information. A matched pairwise randomization procedure was used with pairs
based on sex and on the Beck Anxiety Inventory score (BAI; Beck and Steer, 1993) recorded
at the pre-treatment assessment.
Power
The effect size estimates were based on single studies on physical exercise and CBT with
comparable participants and methods, as well as comparable or equivalent primary outcome
measures (Broocks et al., 1998; Clark et al., 1994; Clark et al., 1999). An effect size (Cohen’s
d) of at least 0.9 in favour of CBT was expected when comparing the interventions on primary
outcome measures. With an allocation ratio of 1, an alpha level of .05, and a power-level of
.80 (one-tailed), analysis using Gpower (Faul, Erdfelder, Lang and Buchner, 2007) indicated
that a total number of 32 subjects (16 in each group) would be sufﬁcient.
Therapists
Physical exercise. All sessions of physical exercise were led by a team of three treatment
providers: one specialized physiotherapist, one occupational therapist and one psychiatric
nurse. Both the physiotherapist and the psychiatric nurse had extensive experience (>10
years) in supervising physical exercise for groups of psychiatric patients. The occupational
therapist had top level track and ﬁeld experience and was highly experienced in coaching and
supervising athletes.
CBT. The cognitive behaviour therapy was conducted by a team of two specialist clinical
psychologists with post-graduate qualiﬁcations in cognitive therapy. The two therapists had
more than 15 years of experience as clinical psychologists, including more than 5 years of
experience with the clinical application of cognitive therapy. Both had more than 5 years of
experience in administering group treatment.
Interventions
Both treatments were administered in groups and ran for 12 weeks. Physical exercise was
conducted three times per week, and CBT was conducted once a week. For each intervention,
a booster session was offered 3 months following the termination of the treatment period.
There was no contact between participants across interventions. An overview and comparison
of the interventions is provided in the Appendix.
Physical exercise. Physical exercise was conducted according to a manual designed at
the clinic by the physiotherapist from the treatment team and the ﬁrst author. This manual
was developed in cooperation with an expert in the ﬁeld of physical exercise (EWM). The
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frequency and duration of exercises were based on recommendations from previous research
on physical exercise with subjects suffering from anxiety (Martinsen, Hoffart and Solberg,
1989; Meyer and Broocks, 2000; Petruzzello et al., 1991) and recommendations regarding
physical exercise for healthy adults (Haskell et al., 2007). Content in each session was also
in accordance with the speciﬁc recommendations for these types of exercise (Pollock et al.,
1998). As recommended (Meyer and Broocks, 2000), initial treatment sessions progressed
carefully to allow the participants to adjust to the treatment stimulus. Studies have shown
that, compared with healthy volunteers, anxiety symptoms increase as a function of exercise
intensity for PD-patients, but that when they manage to perform the exercise, the likelihood
of anxiety and panic is reduced (Stein et al., 1992). A pilot including eight patients previously
admitted at the centre was conducted to ensure the practical feasibility and motivational
properties of the manual. The manual consisted of three different types of sessions that
were repeated weekly on set days. Day 1 focused on increasing aerobic ﬁtness, and sessions
consisted of 60 minutes of long-distance walking/running outdoors in steep terrain with
interval exercises performed at the end of sessions. Intensity was monitored through the use
of ﬁtness heart rate monitors (Polar F4TM Fitness Heart Rate Monitor with chest strap), and
participants were instructed to stay within the pre-programmed zone of 60–80% of maximum
heart rate (HRmax) for two-thirds of the session. HRmax was calculated by the ﬁtness heart rate
monitor according to the formula HRmax = 220 – age; the standard formula for estimating
HRmax based on such devices (Nes, Janszky, Wisløff, Støylen and Karlsen, 2012). Adherence
to the prescribed intensity was monitored by the supervisors.
Day 2 focused on increasing muscular strength through circuit training. The circuit
consisted of 9 different exercises that were performed for 60 seconds, with a 15-second break
between each exercise and a 2-minute break between each circuit. Session durations increased
from 30 to 45 minutes as the number of circuits correspondingly increased from 2 to 3 as
treatment progressed. On day 3, exercises that varied in intensity were performed, including
sports and games with elements of competition. These exercises lasted approximately
60 minutes. All sessions were preceded by an introduction, warm-up exercises and stretching,
and ended with a short debrieﬁng. Due to this the total duration for each session was
approximately 90 minutes. The manual was designed to ensure that the duration and intensity
of the various exercises increased over the treatment period. The participants were also
supervised individually to ensure compliance and progression, and intensities were generally
high across the different types of sessions.
Participants were initially briefed regarding the physical sensations they might experience
during exercises and the similarity of these sensations to certain anxiety symptoms. This
was done in accordance with previous knowledge about the initiation of physical exercise
in this group of patients (Meyer and Broocks, 2000). During treatment sessions, conversation
focused on the execution of the different exercises and practical issues pertaining to exercise
in general. Treatment was always administered by two members of the treatment team.
Session attendance was monitored, and participants who were unable to participate on a given
occasion were instructed to perform an equivalent exercise on their own and to record details
of the exercise on a provided form (this was not recorded as treatment attendance).
CBT. Therapy was based on the model for PD developed by David Clark and colleagues,
with an emphasis on cognitive restructuring and behavioural experiments (Clark, 1986; Clark
et al., 1994, 1999). Although Clark et al. refer to this treatment as cognitive therapy, treatment
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in the current study included other components that are central to CBT for PD (Gould,
Otto and Pollack, 1995), including exposure to somatic sensations as well as situational
exposure. Therapy is therefore referred to as CBT. The treatment manual was developed by
the therapists, with the content and treatment progression customized for group sessions. The
manual was evaluated by two independent experts on cognitive treatment of PD (Asle Hoffart,
personal communication, 28 September 2007; Hans M. Nordahl, personal communication, 28
August 2007), and was judged to be in accordance with the panic model by David Clark
and colleagues. Treatment content focused on identifying catastrophic misinterpretations,
assessing safety behaviours and establishing alternative hypotheses for the bodily sensations.
Exposure to somatic sensations was performed in group using hyperventilation and physical
exertion. Situational exposure was mainly performed individually as homework between
sessions. When deemed necessary for further progress, participants performed situational
exposure accompanied by one of the therapists during part of the ﬁnal sessions. Treatment
was always administered by both members of the treatment team. Every session lasted
approximately 2 hours, and included a brief assessment of symptom severity, as well as
evaluation and planning of homework.
Treatment ﬁdelity
As CBT represented the control condition in the present study, additional measures were
taken to ensure that the quality and integrity of this intervention were satisfactory. A total
of six treatment-sessions were randomly selected, evaluated and rated, thus covering half of
the total treatment content for the intervention. This evaluation was performed on-site by
an observer (a specialist clinical psychologist that was formally qualiﬁed as a supervisor of
cognitive therapy by the Norwegian Association for Cognitive Therapy). The observer had
personal experience with delivering CBT for PD. The quality of the cognitive therapy was
scored on the Cognitive Therapy Adherence and Competence Scale (CTACS; Barber, Liese
and Abrams, 2003). The random selection of sessions was devised to ensure that the rated
sessions were selected both from the initial as well as the ﬁnal stages of the treatment period.
Between sessions, the therapists received supervision from a different specialist in clinical
psychology who also was formally qualiﬁed as a supervisor of cognitive therapy.
Measures
All outcome measures were adapted from English to the participant’s native language by a
translation and back-translation procedure.
Primary outcome measures: Agoraphobia. The Agoraphobia Cognitions Questionnaire
(ACQ; Chambless et al., 1984) and the Mobility Inventory (MI; Chambless, Caputo, Jasin,
Gracely and Williams, 1985) were used to evaluate agoraphobic cognitions and behaviours
respectively. The ACQ is a 14-item questionnaire assessing the frequency of thoughts that are
common in agoraphobia and is considered to be as measure of fear of fear. Items are rated on
a scale ranging from 1 (thought never occurs when I am nervous) to 5 (thought always occurs
when I am nervous). The Cronbach’s alpha for ACQ at baseline in the present study was .75.
The MI is a 27-item questionnaire designed to assess the frequency of avoidance for a range
of situations relevant to daily life. The MI consists of two subscales assessing avoidance for
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these situations both when alone and when accompanied. Items are rated on a scale ranging
from 1 (never avoid) to 5 (always avoid). The subscales of MI are here referred to as MI-Alone
and MI-Accompanied. The two MI subscales also provide estimates of an individual’s actual
freedom of movement, and therein their level of recovery through treatment. In the present
study, Cronbach’s alphas at baseline for MI-Alone and MI-Accompanied were .91 and .88,
respectively.
Bodily sensitivity. Alertness to bodily sensations was measured by the Body Sensations
Questionnaire (BSQ; Chambless et al., 1984). The BSQ is a 17-item questionnaire designed
to measure fear of bodily sensations, and it provides a list of sensations that may occur when
the person is anxious or in a feared situation. Items appear on a scale ranging from 1 (not at
all frightened by this sensation) to 5 (extremely frightened by this sensation). The Cronbach’s
alpha at baseline for the BSQ in the present study was .87.
Panic Attack Scale. Both panic frequency and panic-related distress and disability were
assessed together using a 2-item scale, with one item for each domain. The scale was
completed by the participants as well as by a clinical psychologist (the ﬁrst author). This
corresponds to the procedure described by Clark et al. (1994, 1999). Panic attack frequency
was measured on a 5-point scale ranging from 0 (no panic attacks) to 4 (one or more panic
attacks per day). Panic-related distress and disability was measured on a 9-point scale running
from 0 (not at all disturbing) to 8 (very disturbing).
Secondary outcome measures: General anxiety. General anxiety was measured both with
the Beck Anxiety Inventory (BAI; Beck and Steer, 1993) and the State-Trait Anxiety Inventory
(STAI; Spielberger, Gorsuch, Lushene, Vagg and Jacobs, 1983). The BAI is comprised of 21
items describing subjective, somatic, or panic-related symptoms. Each item is scored on a
scale with values ranging from 0 (not at all) to 3 (severely – I could barely stand it). The
Cronbach’s alpha at baseline for the BAI in the present study was .89. The STAI consists
of two separate 20-item scales designed to assess both state and trait levels of anxiety. Both
scales ask subjects to rate the degree to which each item applies to them on a scale ranging
from 1 (not at all) to 4 (very much). The STAI-S (state) is comprised of a list of 20 statements
that assess the degree of anxiety and tension one feels at the current moment. The STAI-T
(trait) is comprised of a list of 20 different statements regarding the degree of anxiety and
tension one feels in general. In the present study, Cronbach’s alpha at baseline for both the
STAI-S and the STAI-T was .91.
Depression. Level of depression was assessed using the Beck Depression Inventory II
(BDI-II; Beck, Steer and Brown, 1996). The inventory is comprised of 21 items, all of which
were scored on a 4-point scale (0–3) that aimed to reﬂect the levels of severity of the symptom
in question. The Cronbach’s alpha at baseline for the BDI-II in this study was .87.
Quality of life. The Quality of Life Inventory (QoLI; Frisch, Cornell, Villanueva and
Retzlaff, 1992) assesses 16 different areas of life. Each area is rated on two scales, with
one scale measuring the importance of this particular area to the individual, and the other
the individual’s level of satisfaction with the area in question. The score for each area is made
up by the product of the scores for satisfaction (rated on a 6-point scale ranging from -3 to
3) and importance (rated on a 3-point scale ranging from 0 to 2). Areas rated with a zero for
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importance were not included in the calculation of the overall mean (ranging from -6 to 6).
The Cronbach’s alpha at baseline for the QoLI in this study was .80.
Additional measures: Quality of therapy. The Cognitive Therapy Adherence and
Competence Scale (CTACS; Barber et al., 2003) is a 21-item rating scale assessing the quality
of cognitive therapy that covers both adherence to the therapy manual and the competence
with which therapy is delivered. Items cover various aspects deemed relevant to the adequate
delivery of cognitive therapy, with each item rated from 0 (poor) to 6 (excellent) for both
adherence and competence. Based on this, a mean score may be calculated for each domain.
In addition, one item speciﬁcally assesses the therapist’s overall performance. The Cronbach’s
alpha over the 6 ratings in this study was .93 for both the adherence-items and competence-
items.
Six-minute walk test. The 6-minute walk test (6MWT) is a self-paced measurement of
sub-maximal levels of functional capacity. It is a simple test in which subjects are instructed
to walk, and not run, as far as possible within 6 minutes on a ﬂat and straight corridor. It has
been widely used in samples where participants suffer from cardiac or pulmonary disease, but
also with subjects with other impairments, such as ﬁbromyalgia, and has been shown to be
both valid and reliable in such samples (King et al., 1999). Assessment in the current study
was conducted according to developed guidelines (Crapo et al., 2002), with a corridor of
12.5 meters.
All of the above measures except the 6MWT were administered ﬁve times: at baseline, pre-
treatment, post-treatment, the 6-month follow-up and the 12-month follow-up. The 6MWT
was assessed only at pre- and post-treatment. As the 12-month follow-up assessment was
conducted via postal mail, the clinician rated versions of panic frequency and panic-related
distress and disability were not administered at this assessment. For the 12-month follow-up
assessment, two additional questions were provided in addition to the standard questionnaires
referred to above. These two questions assessed treatment-seeking behaviour as well as
changes in medication that occurred during the year following the treatment period and
were phrased in the following manner (here translated into English): 1) “Have you entered
into a new therapeutic treatment directed at your panic disorder following termination
of the treatment in the study?” and 2) “Have you been prescribed new psychotropic
medication directed at your panic disorder, or changed your current prescription, following
the termination of the treatment in the study?”. For both questions, participants were prompted
to provide further information if they responded positively.
Statistical procedures
Differences in the characteristics of the participants assigned to the two interventions were
assessed using t-tests for independent samples for the continuous variables and the Fisher’s
exact test for the categorical variables.
All subjects were included in all analyses of outcome according to the principle of
intention-to-treat (ITT). Last Observation Carried Forward (LOCF) was used for the
participants who failed to complete treatment, declined to participate at either one or both
follow-up assessments, or where contact could not be established. For the inventories, missing
data were replaced by the mean of the recorded values, provided that no more than 20% of
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the values were missing. If more than 20% of the values were missing, the data were deemed
invalid, and values were substituted by LOCF.
Due to the multiple outcome measures in this study, analyses were performed in a two-step
procedure in order to avoid loss of power due to multiple testing and to reduce the likelihood
of a type I error. Initially, four doubly two-way (Time×Group) repeated measure MANOVAs
were performed in order to investigate the main effects on the primary and secondary outcome
measures. For the primary outcome measures, the ﬁrst MANOVA included the following
four inventories: MI-Alone, MI-Accompanied, ACQ and BSQ. Separate MANOVAs were
performed on the single item scales of panic frequency and panic-related distress and
disability. As the clinician-rated versions were not administered at the 12-month follow-up,
separate MANOVAs had to be conducted for the self-report versions and the clinician-rated
version of these scales. Finally, all secondary outcome measures were analyzed together
in one MANOVA. If a signiﬁcant Time×Group effect was detected, separate two-way
(Time×Group) repeated measures ANOVAs were performed on the implicated outcome
measures. Within-groups effects of treatment with reference to baseline levels were assessed
using t-tests, and bias from multiple comparisons was controlled for with Bonferroni-
corrections. All analyses were conducted using PASW (SPSS) version 17.0.
Effect sizes. Effect-sizes (ES) are reported as Cohen’s d, based on pooled standard
deviations (Cohen, 1988).
Reliable and clinically signiﬁcant change. Reliable and clinically signiﬁcant changes
were analyzed according to the recommendations by Jacobson and Truax (1991). The
Mobility Inventory–Alone subscale was considered the most suitable for assessing clinical
improvement and recovery, as it aims to measure an individual’s freedom (or restriction)
of movement. For change within a subject to be considered reliable, it had to exceed the
calculated Reliable Change Index (RCI). For the assessment of clinically signiﬁcant change,
method C as referred to in Jacobson and Truax (1991) was considered the most appropriate.
According to this method, a midpoint between the normal and the clinical population is
estimated. When a subject’s mean score falls closer to the mean of the normal population
than to that of the clinical population, the change is considered to be clinically signiﬁcant,
provided that this change is also reliable according to the RCI. For a subject to be considered
recovered, he or she also had to fulﬁl an additional criterion as recommended by D. Clark
(personal communication, 22 June 2009) of having zero panic attacks during the last 2 weeks
prior to assessment.
Results
Participant ﬂow and attrition
Of the 141 subjects who made contact with the study’s staff, 66 were invited for a detailed
diagnostic interview (see Figure 1 for an overview of participants’ ﬂow in the study). The most
frequent reasons for exclusion at this stage were either that the symptoms did not indicate
the presence of PD, or that subjects declined participation when informed about the nature
of the study. Of the 66 invited subjects, 36 participants were randomized to either of the
two treatment conditions. Excluded subjects either failed to match inclusion and exclusion
criteria, or declined to participate. A total of four participants (11% of the sample) were
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141 contacted the project and were given information regarding the nature 
of the study. Potential participants were then screened for eligibilty.
75 excluded
No indication of PD (n=28), Substance 
abuse (n=5), Psychotic disorder (n=2), Age 
>50 (n=13), Other (n=1), Declineda (n=26)
30 excluded
No PD (n=13), Substance abuse (n=3),
Age > 50 (n=1), Other (n=3), 
Declineda (n=10)
66 invited for a 
detailed diagnostic 
interview
Randomized (n=36)
Allocated to PE (n=17)
Completed PE (n=17)
Allocated to CBT (n=19)
Completed CBT (n=18)
Did not receive CBT (n=1)
Care providers (n=3), Team (n=1)
Number of patients treated by 
each care provider 
(Mean=2.83, Range [2.5, 3.0])
Care providers (n=2), Team (n=1)
Number of patients treated by 
each care provider 
(Mean=3.17, Range [3.0, 3.5])
Entered 6 months follow-up
assessment (n=17)
Completed assessment (n=16)
Declined further assessment (n=1)
Entered 6 months follow-up
assessment (n=18)
Completed assessment (n=14)
Declined assessment (n=2)
No reply/no contact (n=2)
Entered 12 months follow-up
assessment (n=16)
Completed assessment (n=14)
No reply (n=2)
Entered 12 months follow-up
assessment (n=18)
Completed follow-up (n=16)
No reply (n=3)
17 included in primary analysis 19 included in primary analysis
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Figure 1. Consort diagram displaying the process of inclusion, allocation and attrition. PE = physical
exercise
a Includes subjects whose job, studies or distance of travel prevented participation.
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referred for a cardiac evaluation prior to treatment. Only one participant dropped out during
the course of treatment (in the CBT-intervention following the second treatment session).
Thus, 35 participants received treatment as planned. For various reasons, some participants
did not complete the follow-up assessments (see Figure 1). At the 6-month follow-up, one
participant from the physical exercise group declined assessment, while a total of four from
the CBT group were not assessed. At the 12-month follow-up, a total of three participants in
each condition were not assessed. Viewed together, only three participants were not assessed
at either one of the follow-up assessments: one in the physical exercise-condition and two in
the CBT-condition.
Baseline characteristics
Table 1 presents the demographic and clinical characteristics of the participants at baseline.
This Table shows that 80.6% of the participants were female, that 27.7% reported living alone,
and that 47.2% reported full-time employment. Participants had a mean age of 37.9 years, and
a mean of 13.6 total years of education. The mean duration of PD was 10.1 years, and 38.9%
of the sample had previously sought psychotherapy for PD or PD-related symptoms. Tests
of physical ﬁtness indicated no differences between the groups, neither according to the 6-
minute walk test, nor in terms of on-going levels of physical exercise at baseline. The sample
had a mean Body Mass Index of 26.7. Of the total sample, 36.1% used a selective serotonin
reuptake inhibitor (SSRI), and 13.9% reported to have used benzodiazepines intermittently
within the last month. As expected, a large proportion (80.6%) of the participants was also
diagnosed with agoraphobia, and depression was found to be present in 38.9% of the sample.
On average, participants were diagnosed with a mean of 2.1 comorbid axis 1 disorders and
0.4 comorbid axis 2 disorders. The distribution of the various comorbid axis 1 disorders is
presented in detail in Table 1. There were no signiﬁcant differences between the groups in
the listed characteristics. Table 2 summarizes the results for both groups on all outcome
measures and shows that there were no signiﬁcant differences between the groups prior to
treatment. Furthermore, the Bonferroni-corrected within-groups comparisons did not indicate
any signiﬁcant changes from baseline to pre-treatment.
Treatment attendance
The physical exercise group had a mean attendance rate of 88.7% (SD = 10.0) for treatment
sessions. The corresponding rate for the CBT group was 86.0% (SD = 23.6).
Psychotropic medication
Each subject’s use of psychotropic medication was monitored throughout participation, and
converted to daily doses. One-way repeated measures ANOVAs including all ﬁve assessments
were conducted for each intervention, indicating that levels of medication remained stable for
participants in both the physical exercise group, F(2.59, 41.41) = 1.58, p = .213 (Huynh-Feldt
correction) and the CBT group, F(1.70, 30.55) = 0.48, p = .593 (Huynh-Feldt correction).
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Table 1. Baseline characteristics of patients assigned to Physical Exercise (PE) or CBT
All patients PE CBT
(N = 36) (N = 17) (N = 19)
Characteristic N % N % N %
Female 29 80.6 15 88.2 14 73.7
Marital status (e.g. living alone) 10 27.8 7 41.2 3 15.8
Employment 6 months prior to treatment
Full-time employed 17 47.2 10 58.8 7 36.8
Part-time employed 10 27.8 4 23.5 6 31.6
In rehabilitation or on sick leave 4 11.1 1 5.9 3 15.8
Without regular work 3 8.3 2 11.8 1 5.3
Student 2 5.6 0 0 2 10.5
Mean SD Mean SD Mean SD
Age (years) 37.9 8.6 38.1 8.6 37.8 8.9
Years of education 13.6 2.5 13.9 2.5 13.4 2.5
Duration of PD 10.1 9.5 12.3 10.7 8.2 8.1
Test of physical ﬁtness level (6MWT) 570.5 90.1 593.1 70.5 550.3 103.7
Body Mass Index 26.7 5.8 26.9 6.2 26.6 5.5
N % N % N %
Physical exercisea 10 27.8 5 29.4 5 26.3
Medication
SSRIs 13 36.1 7 41.2 6 31.6
Benzodiazepinesb 5 13.9 3 17.6 2 10.5
Previous treatment for PD 14 38.9 6 35.3 8 42.1
Agoraphobia 29 80.6 13 76.5 16 84.2
Axis 1 comorbidity
Depression 14 38.9 6 35.3 8 42.1
Social phobia 15 41.7 8 47.1 7 36.8
Single phobia 17 47.2 7 41.2 10 52.6
Generalised Anxiety Disorder 16 44.4 8 47.1 8 42.1
Health anxiety 8 22.2 5 29.4 3 15.8
Obsessive-Compulsive Disorder 3 8.3 1 5.9 2 10.5
Mean SD Mean SD Mean SD
Number of comorbid axis 1 disorders 2.1 1.2 2.2 1.4 2.1 0.9
Number of comorbid axis 2 disorders 0.4 0.6 0.4 0.6 0.4 0.6
Notes: No signiﬁcant (p < .05) group differences were found. Both 6MWT and Body Mass Index
(BMI) were assessed at pre-treatment. aRefers to ongoing (within last 14 days) level of physical exercise
recommended for cardiorespiratory ﬁtness or muscular strength as recommended by ACSM (Pollock
et al., 1998).bRefers to the intermittent use of benzodiazepines (Valium, Stesolid, Imovane) within the
last month.
Analysis of outcome measures
Between-groups effects: primary outcome measures. Please refer to Table 2 for values,
effects, and the comparisons of the two treatments. Doubly two-way (Time×Group) repeated
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Table 2. Analyses of outcome measures
Treatments Comparisons
Physical Exercise CBT Between-groups
(n = 17) (n = 19) effects
Time × Group
Outcome measures Mean (SD) ES Mean (SD) ES ES 95% CI F
Primary Outcome Measures – Inventories – MANOVA 1.71 (16, 544)∗
Mobility Inventory (MI) – Alone – ANOVA 3.75 (2.28, 77.61)∗
Baseline 2.42 (0.57) 2.37 (0.78) 0.07 [−0.58, 0.73]
Pre-treatment 2.38 (0.65) −0.06 2.40 (0.70) 0.04 −0.02 [−0.68, 0.63]
Post-treatment 1.98 (0.74) a −0.65 1.55 (0.55) a −1.18 0.65 [−0.02, 1.32]
6-month follow-up 1.93 (0.75) a −0.71 1.59 (0.76) a −0.98 0.44 [−0.22, 1.10]
12-month follow-up 2.04 (0.68) a −0.59 1.61 (0.75) a −0.98 0.59 [−0.08, 1.26]
Mobility Inventory (MI) – Accompanied – ANOVA 3.93 (2.19, 74.28)∗
Baseline 1.79 (0.43) 1.98 (0.70) −0.32 [−0.97, 0.34]
Pre-treatment 1.79 (0.55) 0.01 1.92 (0.58) −0.09 −0.21 [−0.87, 0.45]
Post-treatment 1.61 (0.61) −0.33 1.39 (0.53) a −0.92 0.36 [−0.29, 1.02]
6-month follow-up 1.51 (0.55) −0.54 1.44 (0.62) a −0.79 0.12 [−0.53, 0.78]
12-month follow-up 1.64 (0.54) −0.30 1.41 (0.58) a −0.87 0.41 [−0.25, 1.07]
Agoraphobic Cognitions Questionnaire (ACQ) – ANOVA 1.15 (2.11, 71.62)
Baseline 2.30 (0.52) 2.23 (0.61) 0.13 [−0.52, 0.79]
Pre-treatment 2.23 (0.45) −0.16 2.12 (0.49) −0.20 0.23 [−0.43, 0.89]
Post-treatment 1.85 (0.58) a −0.80 1.50 (0.38) a −1.40 0.70 [0.03, 1.38]
6-month follow-up 1.75 (0.52) a −1.04 1.44 (0.33) a −1.58 0.72 [0.05, 1.40]
12-month follow-up 1.76 (0.55) a −0.99 1.50 (0.35) a −1.45 0.57 [−0.10, 1.24]
Body Sensations Questionnaire (BSQ) – ANOVA 4.08 (2.81, 95.43)∗
Baseline 2.86 (0.60) 2.72 (0.75) 0.20 [−0.45, 0.86]
Pre-treatment 2.55 (0.55) −0.54 2.48 (0.71) −0.32 0.10 [−0.56, 0.75]
Post-treatment 2.25 (0.80) a −0.85 1.55 (0.43) a −1.87 1.07 [0.37, 1.77]
6-month follow-up 2.13 (0.68) a −1.11 1.57 (0.54) a −1.73 0.90 [0.21, 1.59]
12-month follow-up 2.12 (0.69) a −1.12 1.70 (0.63) a −1.45 0.64 [−0.03, 1.31]
Primary Outcome Measures – Single Item Scales – Self-report – MANOVA 1.00 (8, 272)
Panic-related distress/disability (0–8; Self-report)
Baseline 5.94 (2.05) 6.42 (1.64) −0.25 [−0.91, 0.40]
Pre-treatment 5.76 (1.75) −0.09 6.11 (1.49) −0.19 −0.21 [−0.87, 0.44]
Post-treatment 2.82 (2.74) a −1.26 1.79 (1.87) a −2.57 0.43 [−0.23, 1.10]
6-month follow-up 2.00 (2.24) a −1.80 1.74 (2.05) a −2.47 0.12 [−0.54, 0.77]
12-month follow-up 3.06 (2.88) a −1.13 2.00 (2.13) a −2.27 0.41 [−0.25, 1.07]
Panic frequency (0–4; Self-report)
Baseline 1.47 (1.13) 1.79 (1.32) −0.25 [−0.91, 0.40]
Pre-treatment 1.35 (1.12) −0.10 1.68 (1.34) −0.08 −0.26 [−0.92, 0.40]
Post-treatment 0.76 (1.25) −0.58 0.68 (0.95) −0.95 0.07 [−0.58, 0.73]
6-month follow-up 0.53 (1.13) −0.82 0.58 (0.90) a −1.05 −0.05 [−0.70, 0.61]
12-month follow-up 0.82 (1.13) −0.56 0.47 (0.77) a −1.20 0.36 [−0.30, 1.02]
Primary Outcome Measures – Single Item Scales – Clinician-rated – MANOVA 0.75 (6, 204)
Panic-related distress/disability (0–8; Clinician-rated)
Baseline 6.53 (1.42) 6.79 (1.32) −0.19 [−0.84, 0.47]
Pre-treatment 6.24 (1.72) −0.18 6.21 (1.81) −0.36 0.02 [−0.64, 0.67]
Post-treatment 2.82 (2.79) a −1.64 2.37 (2.50) a −2.17 0.17 [−0.49, 0.82]
6-month follow-up 2.59 (2.81) a −1.73 2.11 (2.31) a −2.44 0.18 [−0.47, 0.84]
Panic frequency (0–4; Clinician-rated)
Baseline 1.35 (1.12) 1.79 (1.36) −0.34 [−1.00, 0.31]
Pre-treatment 2.00 (1.32) 0.52 1.58 (1.39) −0.15 0.30 [−0.36, 0.96]
Post-treatment 0.76 (1.25) −0.49 0.63 (0.90) a −0.99 0.12 [−0.54, 0.77]
6-month follow-up 0.65 (1.22) −0.58 0.58 (0.96) a −1.01 0.06 [−0.59, 0.72]
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Table 2. Continued.
Treatments Comparisons
Physical Exercise CBT Between-groups
(n = 17) (n = 19) effects
Time × Group
Outcome measures Mean (SD) ES Mean (SD) ES ES 95% CI F
Secondary Outcome Measures – Inventories – MANOVA 1.16 (20, 540)
Beck Anxiety Inventory (BAI)
Baseline 27.76 (10.89) 26.37 (9.71) 0.13 [−0.52, 0.79]
Pre-treatment 22.06 (10.78) −0.51 22.32 (10.46) −0.39 −0.02 [−0.68, 0.63]
Post-treatment 15.65 (14.18) a −0.94 10.11 (7.71) a −1.82 0.48 [−0.18, 1.15]
6-month follow-up 13.59 (11.89) a −1.21 9.42 (8.51) a −1.82 0.40 [−0.26, 1.06]
12-month follow-up 13.95 (11.81) a −1.19 10.59 (9.82) a −1.58 0.30 [−0.35, 0.96]
State Trait Anxiety Inventory – Trait (STAI-T)
Baseline 50.06 (10.76) 54.47 (9.00) −0.44 [−1.10, 0.22]
Pre-treatment 50.18 (13.11) 0.01 51.32 (8.61) −0.35 −0.10 [−0.76, 0.55]
Post-treatment 43.71 (13.93) −0.50 42.16 (10.19) a −1.25 0.13 [−0.53, 0.78]
6-month follow-up 42.65 (13.40) a −0.60 41.93 (10.92) a −1.23 0.06 [−0.60, 0.71]
12-month follow-up 43.18 (14.14) −0.53 41.21 (10.65) a −1.32 0.15 [−0.50, 0.81]
State Trait Anxiety Inventory – State (STAI-S)
Baseline 44.41 (9.62) 43.11 (8.66) 0.14 [−0.52, 0.80]
Pre-treatment 41.35 (11.29) −0.28 42.16 (8.76) −0.11 −0.08 [−0.73, 0.58]
Post-treatment 36.65 (11.96) −0.70 35.42 (10.15) a −0.80 0.11 [−0.55, 0.76]
6-month follow-up 35.82 (9.75) a −0.87 33.53 (9.74) a −1.02 0.23 [−0.43, 0.89]
12-month follow-up 36.59 (14.31) −0.63 38.37 (10.95) −0.47 −0.14 [−0.79, 0.52]
Beck Depression Inventory II (BDI-II)
Baseline 18.24 (10.28) 21.89 (7.78) −0.40 [−1.06, 0.27]
Pre-treatment 14.59 (9.27) −0.36 19.00 (8.99) −0.34 −0.47 [−1.14, 0.19]
Post-treatment 9.71 (9.25) a −0.85 10.58 (9.29) a −1.29 −0.09 [−0.75, 0.56]
6-month follow-up 9.71 (8.77) a −0.87 11.32 (8.06) a −1.31 −0.19 [−0.84, 0.47]
12-month follow-up 10.18 (11.13) a −0.73 11.16 (8.99) a −1.25 −0.10 [−0.75, 0.56]
Quality of Life Inventory (QoLI)b
Baseline 1.34 (1.52) 1.08 (1.26) −0.19 [−0.47, 0.84]
Pre-treatment 1.19 (1.18) 0.11 0.90 (1.52) 0.13 −0.21 [−0.44, 0.87]
Post-treatment 1.64 (1.33) −0.20 1.56 (1.65) −0.33 −0.05 [−0.61, 0.70]
6-month follow-up 1.87 (1.52) −0.34 1.55 (1.62) −0.32 −0.20 [−0.46, 0.85]
12-month follow-up 1.85 (1.66) −0.31 1.54 (1.84) −0.29 −0.17 [−0.48, 0.83]
Notes: MANOVAs assess combined effects of the different groups of outcome measures. Signiﬁcant results are further
assessed with subsequent ANOVAs for the implicated outcome measures. Effect sizes for each treatment are reported with
reference to baseline values. All effect sizes are calculated with pooled standard deviations. Between-groups effects are
reported with positive values indicating effect in favour of CBT. For the ANOVAs, degrees of freedom were corrected using
Greenhouse-Geisser estimates. ∗ = p < .05. aSigniﬁcant within-group effect from Baseline to corresponding time-point
(Bonferroni-corrected). bValens of effect sizes were changed to be in concordance with the rest of the Table.
measures MANOVAs were performed for the groups on the primary outcome measures, using
Pillai’s trace (V) to evaluate the homogeneity of variance-covariance matrices. The combined
analysis of the four inventories (MI-Alone, MI-Accompanied, ACQ and BSQ) revealed
a signiﬁcant effect of time from baseline to the 12-month follow-up, F(16,544) = 7.28,
p< .01. There was also a signiﬁcant Time×Group interaction (p = .042), which indicates that
the two treatment groups differed over time on the primary outcome measures. Subsequently
conducted repeated measures ANOVAs indicated that there was a signiﬁcant main effect of
16 A. Hovland et al.
Mobility Inventory - Alone
PE
CBT
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
2.6
2.8
M
ea
n 
sc
or
e
Baseline          Pre               Post             6-m. FU        12-m. FU
Mobility Inventory - Accompanied
PE
CBT
1.0
1.2
1.4
1.6
1.8
2.0
2.2
M
ea
n 
sc
or
e
Baseline         Pre               Post             6-m. FU        12-m. FU
Agoraphobic Cognitions Questionnaire
PE
CBT
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
2.6
M
ea
n 
sc
or
e
Baseline          Pre               Post              6-m. FU       12-m. FU
Body Sensations Questionnaire
PE
CBT
1.0
1.5
2.0
2.5
3.0
3.5
M
ea
n 
sc
or
e
Baseline          Pre                Post              6-m. FU      12-m. FU
Figure 2. Physical exercise (PE) and CBT compared over time on the primary outcome inventories. Bars
represent standard error of the mean
time for all four inventories: MI-Alone, F(2.28, 77.61) = 36.44, p < .01; MI-accompanied,
F(2.19, 74.28), p < .01; ACQ, F(2.11, 71.62) = 31.88, p < .01; and BSQ, F(2.81, 95.43) =
41.69, p < .01. For the BSQ there was also a signiﬁcant effect of the intervention regardless
of time, F = 4.46, p = .042. There was a signiﬁcant Time×Group effect for the MI-Alone
(p = .023), MI-Accompanied (p = .021) and BSQ (p = .010), but not for the ACQ (p = .323).
See Figure 2 for a graphical presentation of these results.
A doubly two-way repeated measures MANOVA was also performed on the single-item
self-report scales of panic frequency and panic-related distress and disability. This revealed a
signiﬁcant effect of time, F(8, 272) = 15.48, p < .01, whereas no signiﬁcant Time×Group
effect was found in the combined analysis of these two measures.
An equivalent assessment was performed on the single-item clinician-rated measures of
panic frequency and panic-related distress and disability. A signiﬁcant effect of time was
found, F(6, 204) = 16.69, p< .01. The Time×Group interaction was however not signiﬁcant.
Secondary outcome measures. The corresponding MANOVA performed on the ﬁve
secondary outcome measures revealed a signiﬁcant effect of time, F(20,540) = 5.21, p <
.01. However, the Time×Group interaction was not signiﬁcant, and consequently no further
analysis was performed on the separate inventories. It should be noted that the ﬁve scales
correlated highly for each assessment point, with the mean intercorrelations between the
measures of .57, .57, .71, .70, and .72 for baseline, pre-treatment, post-treatment, 6-month
follow-up and 12-month follow-up respectively.
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Within-groups effects. Within-groups effects were assessed by post-hoc tests comparing
baseline levels with levels at other points in time, with results reported in detail in Table
2. For the CBT group, these analyses yielded signiﬁcant results (p < .05) at the 12-month
follow-up on all measures except the Quality of Life scale and the STAI-S. For the physical
exercise-group, the equivalent analyses yielded signiﬁcant results at the 12-month follow-up
on the following measures: the MI-Alone, the ACQ, the BSQ, both the self-rated- and the
clinician-rated version of panic-related distress and disability, the BAI and the BDI-II.
Effect sizes. Both within- and between-groups effect sizes are summarized in detail in
Table 2. Between-groups effect sizes at the 12-month follow-up were in favour of the CBT-
intervention on all outcome measures, except for the STAI-S, the BDI-II and the Quality of
Life Inventory. The within-groups effect sizes for physical exercise were found to be moderate
on the MI-Alone on all assessments following treatment termination. On the MI-Accompanied
the equivalent assessments showed small to moderate effects, whereas they were all large
on the ACQ and the BSQ. For CBT all effects were large on these outcome measures for
the corresponding assessments. Large effects were found on the reduction of panic-related
distress and disability for both treatments on all assessments following the treatment period,
although the effect sizes were considerably larger for CBT. On panic frequency moderate
effects were found for physical exercise, whereas effects were large for CBT. Self-report and
clinician-rated assessments were consistent for both panic-related distress and disability and
panic frequency. Large effects were also found for both interventions on the BAI and the BDI-
II for all assessments following treatment termination. The interventions differed on the STAI-
T where effects were large for CBT and moderate for physical exercise. Both interventions
yielded moderate to large effects on the STAI-S, and small effects on the QoLI.
Reliable and clinically signiﬁcant change. Figure 3 displays the differences in both
reliable and clinically signiﬁcant change between the two interventions. While 63.2% of
patients treated by CBT had a reliable improvement, this applied only to 35.3% of the patients
in the physical exercise group. However, this difference was not signiﬁcant (p = .181, two-
sided Fisher’s exact test). When the additional criterion of a clinically signiﬁcant change was
added, 52.6% of the CBT group fulﬁlled these criteria as compared to only 11.8% of the
physical exercise group. This difference was signiﬁcant (p = .014, two-sided Fisher’s exact
test). When adding the criterion of freedom from panic attacks, 11.8% of the physical exercise-
group still fulﬁlled these criteria. For the CBT group, the proportion of participants satisfying
the criteria was reduced to 47.4%. However, the difference between the two interventions
remained signiﬁcant (p = .031, two-sided Fisher’s exact test).
Treatment-seeking and change in psychotropic medication at the 12-month follow-up Of
the participants that completed the 12-month follow-up assessment, results showed that seven
participants (50%) in the physical exercise-group had entered new psychotherapy directed
at their panic, as compared to none of the participants in the CBT group (p = .002, two-
sided Fisher’s exact test). Furthermore, three participants in the physical exercise-group had
either increased or been prescribed a new psychotropic medication directed at their panic, as
compared to one in the CBT group (p = .33, two-sided Fisher’s exact test).
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Figure 3. Reliable and clinically signiﬁcant change from baseline to 12 month follow-up. Criteria are
applied to MI – Alone, and are accumulated stepwise. Freedom from panic is based on the score on the
panic frequency-item in the self-report measure Panic Attack Scale. PE = physical exercise. ∗ = p <
.05 (two-sided Fisher’s exact test)
CBT adherence and competence
The quality of the CBT was assessed by CTACS and yielded a mean score of 4.7 for
competence, 4.3 for adherence and 4.8 for the item that speciﬁcally assessed the overall
performance of the therapist. Barber et al. (2003) reported mean values of 3.4 and 3.8 for
adherence and competence, respectively, for cognitive therapy when assessing the criterion
validity of the scale. As both the raters and the therapist in the study by Barber et al. were
carefully selected and highly competent, the reported mean values in the current study suggest
that both the content and delivery of the CBT were highly satisfactory.
Change in physical ﬁtness following treatment
As shown in Table 1, there was no difference between the two interventions on the 6-minute
walk test prior to treatment. Following the treatment-period, the physical exercise-group
walked signiﬁcantly longer than the CBT group, t(34) = 2.15, p = .039, on this test.
Missing data
Single items missing within inventories amounted to 0.12% of the total number of
observations. Total or mean scores on primary and secondary outcome measures that were
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missing due to lacking responses from participants or administrative error amounted to 7.14%
of all observations.
Discussion
Both group CBT and group physical exercise were found to be effective for the treatment
of PD, as assessed by primary and secondary outcome measures in this study. However, the
effects were both greater and more consistent for CBT than for physical exercise. The most
salient differences between the two treatments were seen on the primary outcome measures,
and in particular on the inventories that measured agoraphobic avoidance (MI), fear of fear
(ACQ) and fear of bodily sensations (BSQ). When the effects of the treatments were assessed
in a combined analysis of these inventories, CBT was found to perform signiﬁcantly better.
With these inventories considered separately, CBT performed signiﬁcantly better over time
on all measures with the exception of the one assessing fear of fear. Physical exercise yielded
large effects on both fear of fear and bodily sensations, as did CBT. However, the between-
groups effect sizes indicated a larger effect in favour of CBT on bodily sensations, and
especially at the post-treatment assessment. The effects on avoidance were smaller for both
interventions. Still, they were large for CBT, while moderate and small for physical exercise
on avoidance when alone and when accompanied, respectively. Both interventions reduced the
patients’ experienced distress or disability related to their PD. However, CBT appeared to do
this more effectively. Furthermore, physical exercise did not signiﬁcantly reduce the number
of panic attacks, while CBT did. As the presence of recent panic attacks was not an inclusion
criterion, not all participants experienced frequent attacks, thus the potential for changes in
this domain was limited.
The analysis of the secondary outcome-measures indicated no difference between the two
interventions over time. The results suggested that both interventions had the capacity to
signiﬁcantly reduce both symptoms of depression and general anxiety as measured by the
BAI. The effects of treatment were generally lower as measured by the STAI-T and the STAI-
S, as compared to what was found for the BAI. This is probably due to the fact that BAI, to a
greater extent than the STAI-T and the STAI-S, reﬂects panic-related anxiety symptoms (Cox,
Cohen, Direnfeld and Swinson, 1996).
Overall, we conclude that although physical exercise was associated with improvements on
several outcome measures, CBT appears to yield a better treatment response. Improvement
was also assessed in terms of reliable and clinically signiﬁcant change (Jacobson and Truax,
1991). In the current study, CBT appeared to be more effective than physical exercise
concerning clinically signiﬁcant improvement. This is corroborated by the treatment-seeking
behaviour displayed by participants within the 12 months following treatment termination.
Considering the results from the studies by Broocks et al. (1998) and Clark et al. (1994),
one could argue that the results of the current study were to be expected. Broocks et al.
found that exercise was outperformed by tricyclic antidepressants, whereas Clark et al. (1994)
found cognitive therapy to be superior to a comparable antidepressant (Modigh, Westberg
and Eriksson, 1992). These two studies are similar in methodology to the current study, and
especially in terms of the treatment content. It is therefore also relevant to compare the results
from the current study against what was found in these studies to assess the representativeness
and validity of the results in the current study.
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The current study compares well with the within-groups effect sizes that were found in
the two above mentioned studies on physical exercise and cognitive therapy both in terms of
primary (Bandelow, 1995) and secondary outcome measures. Effect sizes in the current study
are slightly lower for both physical exercise and CBT compared to Broocks et al. (1998)
and Clark et al. (1994), respectively. This could indicate that treatments in the current study
were less effective. However, it could also reﬂect differences in sample characteristics. The
sample of the current study had a longer mean duration of illness; 10.1 years compared to
3.1 (Broocks et al., 1998) and 3.3 (Clark et al., 1994). For the secondary outcome measures
in the study by Broocks et al., only completer data were presented, thus possibly yielding a
somewhat larger effect than that observed with an ITT-sample.
The current study also highlights an important challenge of studying the emotional effects
of physical exercise, namely that of controlling the delivered dose (duration and intensity)
of exercise. Previous studies with clinical samples (Broocks et al., 1998; Martinsen et al.,
1989; Sexton et al., 1989) exerted relatively little control over the intensity during the exercise
sessions. Subjects in these studies either walked or ran, alone or in groups. This contrasts
with the more recent studies on anxiety sensitivity (Broman-Fulks et al., 2004; Broman-Fulks
and Storey, 2008; Smits et al., 2008), where the delivered dose of exercise was carefully
controlled through the use of treadmills. These studies do however also differ in terms of
duration of the interventions, where subjects in the clinical studies performed the exercises for
more than 8 weeks, whereas the subjects in the studies on anxiety sensitivity performed the
exercises for 2 weeks. Previous research has indicated that the treatment should last at least
12 weeks to ensure reductions in trait-anxiety (Petruzzello et al., 1991), and Broocks et al.
(1998) also suggested that a treatment-program longer than their 10 weeks may be necessary
for the physical exercise to be fully effective. Drop-out has been a challenge in studies with
clinical samples (Broocks et al., 1998; Meyer and Broocks, 2000; Sexton et al., 1989), and
longer interventions naturally increase the likelihood for subjects to drop-out. Drop-out is a
threat to the external validity of studies, as it questions the applicability of the intervention
to the relevant population. Because the physical exercise in the current study took place three
times per week over a period of 12 weeks, more varied treatment content was adopted to
try to alleviate drop-out from the treatment. However, this allowed for less control over the
delivered dose of exercise, especially with regard to the intensity of the exercise. As described
in the Methods section, the delivered dose of physical exercise was controlled through the
adherence to a detailed and structured treatment manual, and by having the exercise being
performed under supervision on the site. In addition to this, intensity was monitored with a
ﬁtness heart rate monitor during the sessions intended to increase aerobic capacity. However,
the importance of achieving increased aerobic capacity for participants or the necessity for
participants to perform exercise at a high intensity during treatment sessions is still somewhat
unclear. Though it has been shown that high-intensity exercise can reduce anxiety sensitivity
better than low-intensity exercise (Broman-Fulks et al., 2004; Esquivel et al., 2008), other
studies have indicated that increased aerobic ﬁtness is not necessary to achieve reductions in
anxiety and that resistance training or low-intensity exercise can provide anxiolytic effects
(Martinsen et al., 1989; Meyer and Broocks, 2000; Sexton et al., 1989; Strohle et al., 2009).
Regarding the current study, it is therefore not clear whether the subjects experienced reduced
anxiety levels as a result of changes in aerobic capacity, or as a result of mere participation
in 12 weeks of group physical exercise. Generally, group interventions are known to be
associated with therapeutic beneﬁts due to, for example, social support, normalization, peer
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feedback and role modelling (Yalom and Leszcz, 2005). As such, it is possible that the use
of group format in the present study could have inﬂuenced the treatment effects in both
conditions by the above mentioned mechanisms.
The two interventions differed in frequency of delivery, as physical exercise was performed
three times per week and CBT was performed once a week. As both treatments ran for
12 weeks, this means that the physical exercise-group received three times as many sessions.
However, the two treatments were considered to represent two different packages of treatment
in the current study. Adhering to the recommendations for the duration and frequency of
physical exercise produced a format that could not readily be transferred to the standard
methods of CBT treatment.
The current study had relatively fewer exclusion criteria than has been the case in
comparable studies (Broocks et al., 1998; Clark et al., 1994). This was preferred with
reference to the increased external validity this provides. Greater clinical realism in this
ﬁeld has been encouraged (Lawlor and Hopker, 2001; Salmon, 2001) and, compared to
previous studies, the most noteworthy difference in the inclusion and exclusion criteria
of the current study is the omission of the requirement of participants to have recently
experienced panic attacks. As spontaneous and frequent panic attacks are known to decrease
with time (American Psychiatric Association, 2000), this omission allows for a sample that
has experienced chronic PD. This could obviously inﬂuence effect sizes on some of the
measures as well as the rates of participants acquiring clinically signiﬁcant change. However,
the relatively large difference between the two interventions in terms of reliable and clinically
signiﬁcant change remains noteworthy.
The primary aim of this study was to evaluate the long-term clinical efﬁcacy of physical
exercise by comparing it with CBT, an established treatment for PD. Frequent calls have been
made for the controlled assessment of the anxiolytic effects of physical exercise compared to
an established treatment option within a relevant clinical context. Results here suggest that
group CBT is more effective for treating PD than physical exercise performed in groups.
However, physical exercise in itself yielded large and signiﬁcant effects on the majority of
both primary and secondary outcome measures at both post-treatment and the follow-up
assessments. The current study provides insights into the long-term clinical effects of both
physical exercise and CBT. Regarding physical exercise, a controlled assessment of these
effects has not previously been provided. Both Figure 2 and Table 2 suggest that these effects
do not diminish within the ﬁrst 12 months. However, the assessment of the reliable and
clinically signiﬁcant change does suggest that clinical efﬁcacy should be further explored
before physical exercise can be recommended as a treatment for PD. This is emphasized
by the differences between the two interventions on treatment-seeking behaviour following
treatment termination.
Because physical exercise and CBT might improve panic symptoms by different
mechanisms, future studies should further investigate whether physical exercise combined
with CBT may yield greater improvements than CBT alone. Smits et al. (2008) found that the
effect of physical exercise was not enhanced for subjects with increased anxiety sensitivity
by the addition of a cognitive restructuring-component. Still, other efforts have been made to
combine physical exercise with CBT as a treatment option for anxiety disorders, including PD.
Two separate pilot studies have been conducted (Cromarty, Robinson, Callcott and Freeston,
2004; Merom et al., 2008), and both conclude that such efforts are acceptable to patients
and that further evaluations should be carried out. Further research should also aim to reveal
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whether physical exercise might work better than or as well as CBT for subgroups of patients
suffering from PD.
Strengths and limitations
In the present study, several steps were taken to ensure the integrity of the interventions.
Both treatment options were delivered by experienced therapists and according to a treatment
manual. For the CBT, the treatment integrity was also evaluated by an external observer. An
additional strength of the present study is that both treatments were highly attended and had
low rates of attrition. All patients were assessed twice before the onset of treatment, and results
indicated that no spontaneous recovery had taken place for any of the outcome measures of
either group. Considering the mean duration of illness and the degree of co-morbidity, the
current sample appears to represent the general population of PD patients. The treatments
were analyzed in accordance with the principle of intention-to-treat, thus strengthening the
external validity of the results. To our knowledge, the present study is the ﬁrst RCT with
long-term follow-up assessments that has investigated the clinical effects of physical exercise
on PD.
In terms of study limitations, it should be noted that the therapist ratings were not blinded.
The impact of this on the current study is considered small, as it only applies to two
scales, which were also responded to by way of participant self-report. A more objective
manipulation check than the 6-minute walk test (6MWT) should be preferred. However,
considering the recent ﬁndings on the acute anti-panic effects of a single bout of physical
exercise (Esquivel et al., 2008; Strohle et al., 2009), it is unclear what impact a more
physically demanding test could have on treatment outcome. In terms of treatment content,
the current study emphasized an ecological approach where two different treatment packages
were compared. Although our power analysis indicated that we included a sufﬁcient number
of patients in the present study, certain non-signiﬁcant effects might have been signiﬁcant
if a larger sample size had been used. Even though CBT is considered an evidence-based
treatment for PD, the lack of a no treatment control group in the present study limits the
ability to draw conclusions regarding the overall effectiveness of both interventions, as other
explanations, such as statistical regression or demand effects, cannot be ruled out.
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